Bystolic: Advanced Beta-Blocker Therapy for Hypertension Control
Bystolic
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.63 | $49.00 (0%) | 🛒 Add to cart |
| 60 | $1.27 | $98.00 $76.00 (22%) | 🛒 Add to cart |
| 90 | $1.16 | $147.00 $104.00 (29%) | 🛒 Add to cart |
| 120 | $1.09 | $196.00 $131.00 (33%) | 🛒 Add to cart |
| 180 | $1.04 | $294.00 $187.00 (36%) | 🛒 Add to cart |
| 270 | $1.00
Best per pill | $441.00 $270.00 (39%) | 🛒 Add to cart |
Synonyms | |||
Bystolic (nebivolol) is a third-generation, cardioselective beta-adrenergic blocking agent indicated for the treatment of hypertension. It offers a unique hemodynamic profile, combining beta-1 receptor blockade with vasodilatory properties mediated through endothelial nitric oxide release. This dual mechanism of action provides effective blood pressure reduction while potentially offering a favorable side effect profile compared to traditional beta-blockers. It is a cornerstone in modern antihypertensive regimens, suitable for a wide range of patient demographics.
Features
- Active Pharmaceutical Ingredient: Nebivolol hydrochloride.
- Pharmacological Class: Beta-1 selective adrenergic receptor antagonist with additional nitric oxide-mediated vasodilation.
- Available Strengths: 2.5 mg, 5 mg, 10 mg, and 20 mg film-coated tablets.
- Administration: Oral, once-daily dosing.
- Bioavailability: Approximately 12% in extensive metabolizers; higher in poor metabolizers.
- Half-life: Averages 12-19 hours, supporting 24-hour efficacy with a single dose.
- Excretion: Primarily via hepatic metabolism (CYP2D6) and fecal elimination of metabolites.
Benefits
- Effective Blood Pressure Reduction: Demonstrates significant and consistent reductions in both systolic and diastolic blood pressure in clinical trials.
- Favorable Hemodynamic Profile: Lowers blood pressure by reducing heart rate and cardiac output while decreasing peripheral vascular resistance, unlike traditional non-vasodilating beta-blockers.
- Potential Metabolic Neutrality: Studies suggest a neutral or favorable effect on metabolic parameters, including insulin sensitivity and lipid profiles, which is a distinct advantage for hypertensive patients with metabolic syndrome.
- Cardioselectivity: At the 10 mg dose and below, it exhibits high selectivity for beta-1 adrenergic receptors, minimizing the risk of bronchoconstriction and other beta-2 mediated side effects.
- Vasodilatory Action: The nitric oxide-mediated vasodilation may contribute to improved endothelial function and peripheral blood flow.
- Once-Daily Dosing: Enhances patient adherence and provides 24-hour coverage, including during the early morning surge in blood pressure.
Common use
Bystolic is primarily prescribed for the first-line treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is used to lower elevated blood pressure, thereby reducing the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Its tolerability profile also makes it a consideration for patients who experience adverse effects with other beta-blocker therapies.
Dosage and direction
The recommended starting dose is 5 mg orally once daily, with or without food. Dosage may be increased at 2-week intervals, as needed, to achieve optimal blood pressure control. The full antihypertensive effect is typically seen within 1-2 weeks of reaching a maintenance dose.
- Initial Dose: 5 mg once daily.
- Maintenance Dose: 5 mg to 40 mg once daily. The maximum recommended dose is 40 mg.
- Special Populations:
- Patients with Renal Impairment: In patients with severe renal impairment (CrCl <30 mL/min), the recommended initial dose is 2.5 mg once daily; titrate upward cautiously.
- Patients with Hepatic Impairment: In patients with moderate hepatic impairment, the recommended initial dose is 2.5 mg once daily; titrate upward cautiously. Use in patients with severe hepatic impairment is not recommended.
- CYP2D6 Poor Metabolizers: Consider a lower initial dose, as these patients have approximately a 5-fold higher exposure to nebivolol.
- The tablet should be swallowed whole with a glass of water. It can be taken at any time of day but should be taken consistently at the same time each day.
Precautions
- Abrupt Cessation: Do not abruptly discontinue Bystolic. Beta-blocker therapy should be withdrawn gradually over 1-2 weeks to avoid a potential rebound phenomenon (e.g., tachycardia, hypertension exacerbation, unstable angina).
- Angina Pectoris: May mask certain signs of hyperthyroidism and the tachycardia of hypoglycemia.
- Peripheral Vascular Disease: Use with caution in patients with peripheral vascular disease (e.g., Raynaud’s disease), as beta-blockers can precipitate or aggravate symptoms of arterial insufficiency.
- Anesthesia: Inform the anesthesiologist that the patient is on a beta-blocker therapy prior to any major surgery.
- Pheochromocytoma: Should not be used unless an alpha-blocker is being co-administered.
- Psoriasis: Use with caution in patients with a history of psoriasis.
- Pregnancy: Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
- Lactation: Nebivolol is excreted in human milk. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Contraindications
Bystolic is contraindicated in patients with:
- Severe bradycardia
- Heart block greater than first degree (in the absence of a functioning pacemaker)
- Cardiogenic shock
- Decompensated cardiac failure
- Sick sinus syndrome (unless a permanent pacemaker is in place)
- Severe hepatic impairment (Child-Pugh >B)
- Hypersensitivity to nebivolol or any component of the product
Possible side effect
Most adverse reactions are mild and transient. Common side effects include:
- Headache
- Fatigue
- Dizziness
- Diarrhea
- Nausea
- Insomnia
- Chest pain
- Bradycardia
- Dyspnea
- Rash
- Peripheral edema Less common but serious side effects require immediate medical attention and can include:
- Worsening heart failure
- Severe bradycardia or heart block
- Bronchospasm (in susceptible patients)
- Masked hypoglycemia in diabetics
- Depression
Drug interaction
Concomitant use of Bystolic with other drugs requires careful monitoring:
- Other Antihypertensives: Additive effects on blood pressure lowering and heart rate.
- Antiarrhythmics (e.g., Disopyramide): May have additive effects on myocardial contractility and AV conduction.
- CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine, Quinidine): Can significantly increase nebivolol plasma concentrations. Dose adjustment of Bystolic may be necessary.
- Digoxin: Concomitant use increases the risk of bradycardia.
- Clonidine: Exaggerated rebound hypertension can occur if both drugs are withdrawn simultaneously. Withdraw the beta-blocker several days before the gradual withdrawal of clonidine.
- Calcium Channel Blockers (e.g., Verapamil, Diltiazem): May have additive effects on myocardial contractility, AV conduction, and blood pressure. Increased risk of bradycardia and heart block.
Missed dose
If a dose is missed, it should be taken as soon as possible on the same day. If it is almost time for the next scheduled dose, the missed dose should be skipped. Do not double the next dose to make up for a missed one.
Overdose
Symptoms of overdose are primarily related to excessive beta-blockade and may include:
- Severe bradycardia
- Heart failure
- Hypotension
- Bronchospasm
- Hypoglycemia In case of suspected overdose, seek immediate medical attention. Treatment is primarily supportive and symptomatic. Based on the pharmacologic profile, atropine, glucagon, or isoproterenol may be considered. In refractory cases, transvenous cardiac pacing may be required.
Storage
Store Bystolic tablets at room temperature, 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep the bottle tightly closed and protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the bottle.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“Bystolic has been a game-changer in my practice for managing hypertension in patients who were intolerant of older beta-blockers. The vasodilatory effect and lack of significant metabolic side effects make it a superior choice for many, particularly those with comorbid metabolic syndrome. Patient adherence is high due to the once-daily dosing and generally favorable side effect profile.” – Cardiologist, 15 years experience.
“In my patient population, the transition to Bystolic from atenolol resulted in marked improvements in reported fatigue and sexual dysfunction, two common reasons for non-adherence. Its efficacy in controlling blood pressure, especially the morning surge, is excellent.” – Internist, 10 years experience.
“While effective, it is crucial to initiate therapy at the appropriate dose, especially in the elderly and those with any degree of renal or hepatic impairment. Starting at 2.5 mg and titrating slowly has minimized initial side effects like dizziness in my patients.” – Clinical Pharmacist Specialist.